Naturally Occurring IgG Antibodies Provide Innate Protection against Vibrio cholerae Bacteremia by Recognition of the Outer Membrane Protein U

Journal of Innate Immunity

Volumn 8, Issue 3, 2016, Pages 269-283

  Aung, Kyaw Min ^a   Sjöström, Annika E ^a   Von Pawel Rammingen, Ulrich ^a   Riesbeck, Kristian ^b   Uhlin, Bernt Eric ^a   Wai, Sun Nyunt ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

C1q; Naturally occurring IgG antibodies; Outer membrane protein U; Outer membrane vesicles; Serum resistance; Vibrio cholerae

Indexed keywords

COMPLEMENT COMPONENT C1Q; IMMUNOGLOBULIN G ANTIBODY; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN U; UNCLASSIFIED DRUG; ADHESIN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; OMPU PROTEIN, VIBRIO CHOLERAE;

ANIMAL CELL; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; CHOLERA; COMPLEMENT CLASSICAL PATHWAY; COMPLEX FORMATION; CONTROLLED STUDY; EXTRACELLULAR TRANSCOMPLEMENTATION; GENETIC COMPLEMENTATION; HUMAN; INNATE IMMUNITY; MEMBRANE VESICLE; NONHUMAN; NORMAL HUMAN; OUTER MEMBRANE VESICLE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SERUM RESISTANCE; VIBRIO CHOLERAE; WILD TYPE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; BACTEREMIA; BACTERIOLYSIS; BLOOD; DISEASE PREDISPOSITION; GENETIC ENGINEERING; GENETICS; HUMORAL IMMUNITY; IMMUNOLOGY; METABOLISM; MOLECULAR CLONING; MUTATION;

ADHESINS, BACTERIAL; ANTIBODIES, BACTERIAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; BACTEREMIA; BACTERIOLYSIS; CHOLERA; CLONING, MOLECULAR; DISEASE SUSCEPTIBILITY; GENETIC ENGINEERING; HUMANS; IMMUNITY, HUMORAL; IMMUNITY, INNATE; IMMUNOGLOBULIN G; MUTATION; VIBRIO CHOLERAE;

EID: 84961223388     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000443646     Document Type: Article

References (44)

1. Blake PA, Weaver RE, Hollis DG: Diseases of humans (other than cholera) caused by vibrios. Annu Rev Microbiol 1980; 34: 341-367.
2. Provenzano D, Lauriano CM, Klose KE: Characterization of the role of the ToxRmodulated outer membrane porins OmpU and OmpT in Vibrio cholerae virulence. J Bacteriol 2001; 183: 3652-3662.
3. Duperthuy M, Schmitt P, Garzon E, Caro A, Rosa RD, Le Roux F, Lautredou-Audouy N, Got P, Romestand B, de Lorgeril J, Kieffer-Jaquinod S, Bachere E, Destoumieux-Garzon D: Use of ompU porins for attachment and invasion of Crassostrea gigas immune cells by the oyster pathogen Vibrio splendidus. Proc Natl Acad Sci USA 2011; 108: 2993-2998.
4. Miajlovic H, Cooke NM, Moran GP, Rogers TR, Smith SG: Response of extraintestinal pathogenic Escherichia coli to human serum reveals a protective role for Rcs-regulated exopolysaccharide colanic acid. Infect Immun 2014; 82: 298-305.
5. Anderson AM, Varkey JB, Petti CA, Liddle RA, Frothingham R, Woods CW: Non-O1 Vibrio cholerae septicemia: case report, discussion of literature, and relevance to bioterrorism. Diagn Microbiol Infect Dis 2004; 49: 295-297.
6. Walport MJ: Complement. First of two parts. N Engl J Med 2001; 344: 1058-1066.
7. Hallstrom T, Riesbeck K: Haemophilus influenzae and the complement system. Trends Microbiol 2010; 18: 258-265.
8. Liu YF, Yan JJ, Lei HY, Teng CH, Wang MC, Tseng CC, Wu JJ: Loss of outer membrane protein C in Escherichia coli contributes to both antibiotic resistance and escaping antibody-dependent bactericidal activity. Infect Immun 2012; 80: 1815-1822.
9. Agarwal V, Ahl J, Riesbeck K, Blom AM: An alternative role of C1q in bacterial infections: facilitating Streptococcus pneumoniae adherence and invasion of host cells. J Immunol 2012; 191: 4235-4245.
10. Avrameas S: Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today 2012; 12: 154-159.
11. Kaveri SV: Intravenous immunoglobulin: exploiting the potential of natural antibodies. Autoimmun Rev 2012; 11: 792-794.
12. Pollack M, Huang AI, Prescott RK, Young LS, Hunter KW, Cruess DF, Tsai CM: Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core. J Clin Invest 1983; 72: 1874-1881.
13. Panda S, Zhang J, Tan NS, Ho B, Ding JL: Natural IgG antibodies provide innate protection against ficolin-opsonized bacteria. EMBO J 2013; 32: 2905-2919.
14. Panda S, Ding JL: Natural antibodies bridge innate and adaptive immunity. J Immunol 2015; 194: 13-20.
15. Vaitkevicius K, Lindmark B, Ou G, Song T, Toma C, Iwanaga M, Zhu J, Andersson A, Hammarstrom ML, Tuck S, Wai SN: A Vibrio cholerae protease needed for killing of Caenorhabditis elegans has a role in protection from natural predator grazing. Proc Natl Acad Sci USA 2006; 103: 9280-9285.
16. Fine DP, Marney SR Jr, Colley DG, Sergent JS, Des Prez RM: C3 shunt activation in human serum chelated with EGTA. J Immunol 1972; 109: 807-809.
17. von Pawel-Rammingen U, Johansson BP, Bjorck L: IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J 2002; 21: 1607-1615.
18. Vindebro R, Spoerry C, von Pawel-Rammingen U: Rapid IgG heavy chain cleavage by the streptococcal IgG endopeptidase IdeS is mediated by IdeS monomers and is not due to enzyme dimerization. FEBS Lett 2013; 587: 1818-1822.
19. Nakasone N, Iwanaga M: Characterization of outer membrane protein OmpU of Vibrio cholerae O1. Infect Immun 1998; 66: 4726-4728.
20. Ishikawa T, Rompikuntal PK, Lindmark B, Milton DL, Wai SN: Quorum sensing regulation of the two hcp alleles in Vibrio cholerae O1 strains. PLoS One 2009; 4:e6734.
21. Wai SN, Mizunoe Y, Takade A, Kawabata S, Yoshida S: Vibrio cholerae O1 strain TSI-4 produces the exopolysaccharide materials that determine colony morphology, stress resistance, and biofilm formation. Appl Environ Microbiol 1998; 64: 3648-3655.
22. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
23. Wai SN, Lindmark B, Soderblom T, Takade A, Westermark M, Oscarsson J, Jass J, Richter-Dahlfors A, Mizunoe Y, Uhlin BE: Vesicle-mediated export and assembly of poreforming oligomers of the enterobacterial ClyA cytotoxin. Cell 2003; 115: 25-35.
24. Rompikuntal PK, Vdovikova S, Duperthuy M, Johnson TL, Ahlund M, Lundmark R, Oscarsson J, Sandkvist M, Uhlin BE, Wai SN: Outer membrane vesicle-mediated export of processed PrtV protease from Vibrio cholerae. PLoS One 2015; 10:e0134098.
25. Rautemaa R, Meri S: Complement-resistance mechanisms of bacteria. Microbes Infect 1999; 1: 785-794.
26. Joens LA, Nuessen ME: Bactericidal effect of normal swine sera on Treponema hyodysenteriae. Infect Immun 1986; 51: 282-285.
27. Steele NP, Munson RS Jr, Granoff DM, Cummins JE, Levine RP: Antibody-dependent alternative pathway killing of Haemophilus influenzae type b. Infect Immun 1984; 44: 452-458.
28. Gaboriaud C, Juanhuix J, Gruez A, Lacroix M, Darnault C, Pignol D, Verger D, Fontecilla-Camps JC, Arlaud GJ: The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J Biol Chem 2003; 278: 46974-46982.
29. Duperthuy M, Sjostrom AE, Sabharwal D, Damghani F, Uhlin BE, Wai SN: Role of the Vibrio cholerae matrix protein Bap1 in crossresistance to antimicrobial peptides. PLoS Pathog 2013; 9:e1003620.
30. Song T, Mika F, Lindmark B, Liu Z, Schild S, Bishop A, Zhu J, Camilli A, Johansson J, Vogel J, Wai SN: A new Vibrio cholerae sRNA modulates colonization and affects release of outer membrane vesicles. Mol Microbiol 2008; 70: 100-111.
31. Pagel M, Simonet V, Li J, Lallemand M, Lauman B, Delcour AH: Phenotypic characterization of pore mutants of the Vibrio cholerae porin OmpU. J Bacteriol 2007; 189: 8593-8600.
32. Xu C, Wang S, Zhaoxia Z, Peng X: Immunogenic cross-reaction among outer membrane proteins of Gram-negative bacteria. Int Immunopharmacol 2005; 5: 1151-1163.
33. Belkaid Y, Hand TW: Role of the microbiota in immunity and inflammation. Cell 2014; 157: 121-141.
34. Mazmanian SK, Round JL, Kasper DL: A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453: 620-625.
35. Miller VL, Taylor RK, Mekalanos JJ: Cholera toxin transcriptional activator toxR is a transmembrane DNA binding protein. Cell 1987; 48: 271-279.
36. Casadaban MJ: Transposition and fusion of the lac genes to selected promoters in Escherichia coli using bacteriophage lambda and Mu. J Mol Biol 1976; 104: 541-555.
37. Benson SA, Decloux A: Isolation and characterization of outer membrane permeability mutants in Escherichia coli K-12. J Bacteriol 1985; 161: 361-367.
38. Thelin KH, Taylor RK: Toxin-coregulated pilus, but not mannose-sensitive hemagglutinin, is required for colonization by Vibrio cholerae O1 El Tor biotype and O139 strains. Infect Immun 1996; 64: 2853-2856.
39. Chatterjee S, Mondal AK, Begum NA, Roychoudhury S, Das J: Ordered cloned DNA map of the genome of Vibrio cholerae 569B and localization of genetic markers. J Bacteriol 1998; 180: 901-908.
40. Taylor RK, Miller VL, Furlong DB, Mekalanos JJ: Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc Natl Acad Sci USA 1987; 84: 2833-2837.
41. Song T, Sabharwal D, Wai SN: VrrA mediates Hfq-dependent regulation of OmpT synthesis in Vibrio cholerae. J Mol Biol 2010; 400: 682-688.
42. Guzman LM, Belin D, Carson MJ, Beckwith J: Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol 1995; 177: 4121-4130.
43. Furste JP, Pansegrau W, Frank R, Blocker H, Scholz P, Bagdasarian M, Lanka E: Molecular cloning of the plasmid RP4 primase region in a multi-host-range tacP expression vector. Gene 1986; 48: 119-131.
44. Bolivar F, Rodriguez RL, Greene PJ, Betlach MC, Heyneker HL, Boyer HW, Crosa JH, Falkow S: Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene 1977; 2: 95-113.